A carregar...
Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
BACKGROUND: High-dose methotrexate (HD-MTX) with folinic acid (leucovorin) rescue is “gold standard” therapy for osteosarcoma. Plasma concentrations of methotrexate (MTX) are closely related to its efficacy and toxicity. Delayed excretion of MTX can lead to serious adverse reactions that may result...
Na minha lista:
| Publicado no: | Chin Med J (Engl) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5125329/ https://ncbi.nlm.nih.gov/pubmed/27779157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.192781 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|